I recently posted some thoughts on the dilemma drugmakers face in balancing their reporting obligations to FDA against their general ...

It’s clear the opioid crisis is real. It’s not as clear, though, what kind of obligation this crisis might trigger ...

Ultimately, controlling drug pricing is a shell game. Fixing national drug spend promotes a stronger economy (GDP). Negotiating lower Medicare ...

I recently staked my claim that the Class of 2019 drug price reforms don’t include much new, effective, or even ...